The voice-controlled augmented reality device developer has captured $80m in a Teradyne-led series B round, which included Bose Ventures, Qualcomm Ventures and Kopin.

The electronics manufacturer has equipped a corporate venturing subsidiary with an initial $50m to fund early-stage companies developing power and energy technologies.

National Grid Partners and Sistema Asia Fund took part in the round, which increased the conversational software provider's valuation to about $130m.

Immuno-oncology therapy developer Century Therapeutics has emerged from stealth, having been established by Versant Ventures to advance Stanford and Harvard research.

ConnectM Technology has acquired the smart vent maker for an undisclosed sum in a deal that handed exits to Comporium and American Family Ventures.

Rajesh Swaminathan, head of Applied Ventures, spoke to GCV about his unit increasing its investment as it prepares to bring its New York engineering services facility online.

Immuno-oncology therapy developer Century Therapeutics has emerged from stealth, having raised $250m from Leaps by Bayer, which invested $215m, and Fujifilm subsidiary FCDI.

Health management app developer Livongo Health was valued at $800m as of 2018, and a range of corporate investors could exit in the offering.

Carrie Thome, the chief investment officer of Wisconsin Alumni Research Foundation, has left the tech transfer organisation after 18 years.

ConnectM Technology has acquired the smart vent maker for an undisclosed sum in a deal that handed an exit to NYU Innovation Fund.